ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TFFP TFF Pharmaceuticals Inc

2.06
0.01 (0.49%)
01 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
TFF Pharmaceuticals Inc TFFP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.49% 2.06 10:00:00
Open Price Low Price High Price Close Price Previous Close
2.05 2.05 2.11 2.06 2.05
more quote information »

Recent News

Date Time Source Heading
18/5/202406:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/5/202406:05EDGAR2Form 8-K - Current report
15/5/202406:04EDGAR2Form 8-K - Current report
15/5/202406:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202322:07EDGAR2Form 8-K - Current report
16/12/202308:06EDGAR2Form 8-K - Current report
09/12/202308:52EDGAR2Form S-3/A - Registration statement under Securities Act of..
09/12/202308:10EDGAR2Form 8-K - Current report
05/12/202309:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202309:26EDGAR2Form 8-K - Current report
23/11/202309:14EDGAR2Form 8-K - Current report
22/11/202308:41EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202308:06EDGAR2Form 8-K - Current report
05/10/202307:07EDGAR2Form DEF 14A - Other definitive proxy statements
05/10/202307:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/9/202306:16EDGAR2Form PRE 14A - Other preliminary proxy statements
19/9/202307:20EDGAR2Form 8-K - Current report
19/9/202306:10EDGAR2Form 8-K - Current report
18/8/202306:01GLOBETFF Pharmaceuticals Announces Closing of $5.7 Million Public..
17/8/202306:43EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/8/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202320:11EDGAR2Form 8-K - Current report
15/8/202320:00GLOBETFF Pharmaceuticals Prices $5 Million Public Offering of..
15/8/202306:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/8/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]